57.145 LTC-AU Module

[NCEZID] The National Healthcare Safety Network (NHSN)

57.145 Long-Term Care Facilities Antimicrobial Use (LTC-AU) Module-Form

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date: 06/30/2026

Long Term Care Antimicrobial Use (LTC-AU) Module-

Electronic Upload Specification Tables


These data will be collected for each long term care facility resident then uploaded in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Table 1. CDA File Descriptors, Antimicrobial order and resident-level data elements


These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable/Value set

Year

Record the 4-digit year during which the data were collected.

Month

Record the 2-digit month during which the data were collected.

Facility ID

Unique identifier for the long-term care facility. Facility OID

Resident ID

Resident name/identifier

Resident Name: Last

Resident surname

Resident Name: First

Resident first name

Resident Name: Middle

Resident middle name

Gender Identity

Male, Female, Female-to-male transgender, Male-to-female transgender, Identifies as non-conforming, Other, Asked but unknown

Sex at Birth

M (Male) or F (Female); O (other)

Race

American Indian or Alaska Native Asian; Black or African American; Native Hawaiian or Other Pacific Islander; White; Declined to respond; Unknown

Ethnicity

Hispanic or Latino; not Hispanic or Latino; Declined to respond; Unknown

Resident Date of Birth

YYYY/MM/DD

Date Admission to Facility

YYYY/MM/DD

Date of Discharge

YYYY/MM/DD

Discharge Disposition

Description of discharge location (e.g., Home, Another Facility, Hospital, Death)

Antimicrobial

RXNorm codes for antibiotics, antifungals, antivirals (See Table 2)

Antimicrobial Order Start Date

YYYY/MM/DD

Antimicrobial Order End Date

YYYY/MM/DD

Antimicrobial Administration

YYYY/MM/DD/HH/MM/SS

Route

Route of administration: Digestive tract, intravenous route, intramuscular route

Data source

Designates this file as containing data about antimicrobial orders or antimicrobial administrations

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).


Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333 ATTN: PRA (0920-0666).

CDC xx.xxx v1 release number













Table 2. List of Antimicrobials to be Extracted

This is the list of antimicrobials that will be accepted into NHSN as part of the antimicrobial use reporting. Complete list of accepted RxNorm codes is found in the NHSN IDM Workbook.

ACYCLOVIR

CEFUROXIME

MINOCYCLINE

AMOXICILLIN

CEPHALEXIN

MOLNUPIRAVIR

AMOXICILLIN/CLAVULANATE

CIPROFLOXACIN

MOXIFLOXACIN

AMPHOTERICIN B

CLARITHROMYCIN

NAFCILLIN

AMPHOTERICIN B LIPID COMPLEX

CLINDAMYCIN

NIRMATRELVIR

AMPHOTERICIN B LIPOSOMAL

DALBAVANCIN

NITROFURANTOIN

AMPICILLIN

DAPTOMYCIN

OFLOXACIN

AMPICILLIN/SULBACTAM

DICLOXACILLIN

OMADACYCLINE

ANIDULAFUNGIN

DOXYCYCLINE

ORITAVANCIN

AZITHROMYCIN

ERAVACYCLINE

OSELTAMIVIR

AZTREONAM

ERTAPENEM

OXACILLIN

BALOXAVIR MARBOXIL

ERYTHROMYCIN

PENICILLIN G

CASPOFUNGIN

FAMCICLOVIR

PENICILLIN V

CEFACLOR

FIDAXOMICIN

PERAMIVIR

CEFADROXIL

FLUCONAZOLE

PIPERACILLIN/TAZOBACTAM

CEFAZOLIN

FOSFOMYCIN

PLAZOMICIN

CEFDINIR

GANCICLOVIR SODIUM

POSACONAZOLE

CEFEPIME

GENTAMICIN

REMDESIVIR

CEFIDEROCOL

IMIPENEM/CILASTATIN

REZAFUNGIN

CEFIXIME

IMIPENEM/CILASTATIN/RELEBACTAM

SULBACTAM/DURLOBACTAM

CEFOTAXIME

ISAVUCONAZONIUM

SULFAMETHOXAZOLE/TRIMETHOPRIM

CEFOTETAN

ITRACONAZOLE

TEDIZOLID

CEFOXITIN

KETOCONAZOLE

TELAVANCIN

CEFPODOXIME

LEFAMULIN

TETRACYCLINE

CEFPROZIL

LETERMOVIR

TIGECYCLINE

CEFTAROLINE

LEVOFLOXACIN

TINIDAZOLE

CEFTAZIDIME

LINEZOLID

TOBRAMYCIN

CEFTAZIDIME/AVIBACTAM

MEROPENEM

VALACYCLOVIR

CEFTIBUTEN

MEROPENEM/VABORBACTAM

VALGANCICLOVIR

CEFTOLOZANE/TAZOBACTAM

METRONIDAZOLE

VANCOMYCIN

CEFTRIAXONE

MICAFUNGIN

VORICONAZOLE







CDC xx.xxx V1


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleAUR: Microbiology Laboratory Data
AuthorCDC/NCEZID/DHQP
File Modified0000-00-00
File Created2024-09-16

© 2024 OMB.report | Privacy Policy